Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction.
about
Oxytocin and cardioprotection in diabetes and obesityFrom Autism to Eating Disorders and More: The Role of Oxytocin in Neuropsychiatric DisordersA multicenter randomized controlled trial of surgery alone or surgery with atrial natriuretic peptide in lung cancer surgery: study protocol for a randomized controlled trial.Pharmacodynamics of a novel designer natriuretic peptide, CD-NP, in a first-in-human clinical trial in healthy subjects.Autonomic and endocrine control of cardiovascular functionEfficacy of B-Type Natriuretic Peptide Is Coupled to Phosphodiesterase 2A in Cardiac Sympathetic Neurons.Impact of epicardial ablation of concomitant atrial fibrillation on atrial natriuretic peptide levels and atrial function in 6 months follow-up: does preoperative ANP level predict outcome of ablation?Atrial natriuretic peptide protects against bleomycin-induced pulmonary fibrosis via vascular endothelial cells in mice : ANP for pulmonary fibrosis.The role of oxytocin in cardiovascular regulation.Thirty years of research on atrial natriuretic factor: historical background and emerging concepts.Designer natriuretic peptides: a vision for the future of heart failure therapeutics.Diabetic neuropathy and heart failure: role of neuropeptides.M-atrial natriuretic peptide: a novel antihypertensive protein therapy.Targeting reperfusion injury in acute myocardial infarction: a review of reperfusion injury pharmacotherapy.Pharmacologic therapy that simulates conditioning for cardiac ischemic/reperfusion injury.Natriuretic peptides in cardiovascular diseases: current use and perspectivesNatriuretic Peptides as a Novel Target in Resistant Hypertension.Angiotensin II Receptor Blocker Neprilysin Inhibitor (ARNI): New Avenues in Cardiovascular Therapy.Clinical perspectives of urocortin and related agents for the treatment of cardiovascular disease.Long-term miR-669a therapy alleviates chronic dilated cardiomyopathy in dystrophic mice.Do engineered natriuretic peptides have greater therapeutic potential than do native peptides?Atrial natriuretic peptide ameliorates peritoneal fibrosis in rat peritonitis model.Atrial natriuretic peptide protects against cisplatin-induced granulocytopenia.Increased plasma concentrations of midregional proatrial natriuretic Peptide is associated with risk of cardiorenal dysfunction in type 1 diabetes.Atrial natriuretic peptide modified oleate adenosine prodrug lipid nanocarriers for the treatment of myocardial infarction: in vitro and in vivo evaluation.Epigenetic Programming of Synthesis, Release, and/or Receptor Expression of Common Mediators Participating in the Risk/Resilience for Comorbid Stress-Related Disorders and Coronary Artery Disease.Neuroendocrine System Regulatory Mechanisms: Acute Coronary Syndrome and Stress HyperglycaemiaDynamic expression of early responsible genes to acute left-ventricular ischemia in a time-dependent pattern
P2860
Q26748592-7C5F7C35-127C-44ED-B80E-65BB595E7714Q26770469-C86E443B-D422-4BFB-B4AD-92F9880E8889Q30846318-CB487117-FEE8-4E62-A659-89BCC117D8B6Q35086433-35FCEC04-921A-4976-8167-6B553A7DDCDCQ35501160-B1ADF573-447F-4AC1-BC56-D206EE58854AQ35806196-503F23D2-DFAE-4678-B6A4-F2780DA6E51CQ37480127-6FE2897B-A4E0-4662-B21C-E778BC919D0DQ37555854-EF60C827-934C-4240-A908-FF2B24BF80D5Q37696788-45138EB5-1995-4636-93C8-88B8C70D1977Q37889289-8994D1EE-EADE-4A0B-B39F-62074881F6F7Q37911516-BD4DC47A-2E41-4986-B125-6B4AC85085BFQ37914972-B20BEA02-096F-4207-ADCD-893AEDF9B47BQ37963837-E30B5F36-C33A-4A56-93F9-883786F9D06AQ38010782-51ED776D-82A6-4AE5-A674-F3B484F90273Q38137849-BF061B95-4FC6-427C-8D85-0EA252FB4D40Q38162429-8E050365-A10F-4F6F-BFEC-77C5894B7D09Q38371173-89CA6407-E617-4007-B505-A5FD0AC6D21DQ38534772-4D9E60B3-F075-4D43-968C-0AD29D413F6DQ42038020-4D2911D6-027E-4F8A-B2FC-7DEB53825C0DQ42275401-0996EE63-819E-4F83-808F-EF3096D7AAA6Q42382124-61CD05B2-5570-4CB1-8251-325C6CC18455Q44364802-508051ED-46A5-4EC3-9806-6C7C524A42CAQ50237854-28B9FA8F-1963-4993-89CB-9E2A7F284216Q51000313-5A038D90-B389-464C-B872-D32015265BEEQ55255715-D9DF5F4A-72FB-437E-BA31-51F83240242AQ55279696-60235EAA-1D5A-43DB-AFBB-CD12B7E50EF7Q57495851-73DB6BBB-5125-44BE-9A8F-5ABE63648A1BQ58270843-47A1BFFB-96B9-4B3A-B120-7B457199F9F5
P2860
Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effect of atrial natriuretic p ...... h acute myocardial infarction.
@en
Effect of atrial natriuretic p ...... h acute myocardial infarction.
@nl
type
label
Effect of atrial natriuretic p ...... h acute myocardial infarction.
@en
Effect of atrial natriuretic p ...... h acute myocardial infarction.
@nl
prefLabel
Effect of atrial natriuretic p ...... h acute myocardial infarction.
@en
Effect of atrial natriuretic p ...... h acute myocardial infarction.
@nl
P2093
P2860
P921
P356
P1476
Effect of atrial natriuretic p ...... h acute myocardial infarction.
@en
P2093
Masahiko Kurabayashi
Mayumi Furuya
Shu Kasama
Shuichi Ichikawa
Takuji Toyama
P2860
P304
P356
10.1093/EURHEARTJ/EHN206
P577
2008-05-19T00:00:00Z